Endo Health Solutions acquires Boca Pharmacal for $225m
US-based Endo Health Solutions Inc, a specialty pharmaceutical, has reached an agreement to purchase privately-held Boca Pharmacal for $225m to…
Month: August 2013
FDA investigate brain infection in patient receiving Novartis’s MS drug
The case of a patient that has developed a rare and dangerous brain infection while taking Novartis's multiple sclerosis (MS)…
ByRoche reports positive Phase II results for experimental eye drug
Lampalizumab, an experimental eye drug from Roche, has helped slow down the progression of an advanced form of age-related macular…
ByStrathclyde scientists create drug detection computer programme
Researchers from the University of Strathclyde in Glasgow have designed a computer programme aimed at finding smarter drugs to treat…
ByAkorn Inc purchases Hi-Tech Pharmacal for $640m
US-based generic pharmaceutical company Akorn Inc has agreed to buy its national competitor Hi-Tech Pharmacal Co Inc for $640m.
ByHighly specific new antibody introduced to boost HER2 type cancer research
A highly specific HER3 rabbit monoclonal antibody (mAb) developed by use-based Cell Signaling Technology could provide important new information for…
ByCalculator determines the carbon footprint of pharmaceutical products
The Association of the British Pharmaceutical Industry (ABPI), alongside the UK's Carbon Trust, has launched a spreadsheet-based tool that will…
ByAmgen acquires Onyx Pharmaceuticals for $10.4bn
Biotechnology firm Amgen has agreed to acquire US cancer drug producer Onyx Pharmaceuticals for about $10.4bn, offering $125 per share.
By